On January 26, 2026, biote Corp. initiated a voluntary recall of certain hormone pellet lots due to potential metal contamination, expecting to incur about $2.3 million in costs related to the recall including a $1.3 million inventory write-off. The company reassured stakeholders that the recall will not materially impact operations or services to practitioners.